Siren, L.L.C. Arcus Biosciences, Inc. Transaction History

Siren, L.L.C.

  • $2.56 Trillion
  • Q3 2025

A detailed history of Siren, L.L.C. transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 2,912,077 shares of RCUS stock, worth $58.4 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
2,912,077
Previous 1,612,077 80.64%
Holding current value
$58.4 Million
Previous $13.1 Billion 201.81%
% of portfolio
1.55%
Previous 0.68%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$8.22 - $13.6 $10.7 Million - $17.7 Million
1,300,000 Added 80.64%
2,912,077 $39.6 Billion
Q3 2024

Nov 13, 2024
BUY
$13.69 - $18.01 $22.1 Million - $29 Million
1,612,077 New
1,612,077 $24.6 Billion

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.45B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Siren, L.L.C. Portfolio

Follow Siren, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siren, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Siren, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email